Recombinant Mouse Ctsk protein, His-tagged

Cat.No. : Ctsk-2761M
Product Overview : Recombinant Mouse Ctsk protein(P55097)(115-329aa), fused to N-terminal His tag, was expressed in E. coli.
  • Specification
  • Gene Information
  • Related Products
  • Download
Source : E. coli
Species : Mouse
Tag : His
Form : If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol.
If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Molecular Mass : 27.4 kDa
Protein length : 115-329aa
AA Sequence : VPDSIDYRKKGYVTPVKNQGQCGSC WAFSSAGALEGQLKKKTGKLLALSP QNLVDCVTENYGCGGGYMTTAFQYV QQNGGIDSEDAYPYVGQDESCMYNA TAKAAKCRGYREIPVGNEKALKRAV ARVGPISVSIDASLASFQFYSRGVY YDENCDRDNVNHAVLVVGYGTQKGS KHWIIKNSWGESWGNKGYALLARNK NNACGITNMASFPKM
Purity : Greater than 90% as determined by SDS-PAGE.
Storage : Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Reconstitution : Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%.
Gene Name : Ctsk cathepsin K [ Mus musculus ]
Official Symbol : Ctsk
Synonyms : CTSK; cathepsin K; Cat K; minisatellite 10q detected by probe MMS10; catK; Ms10q; MMS10-Q; AI323530;
Gene ID : 13038
mRNA Refseq : NM_007802
Protein Refseq : NP_031828

Not For Human Consumption!

Inquiry

  • Reviews
  • Q&As

Customer Reviews (3)

Write a review
Reviews
09/13/2019

    This guidance can help researchers design and execute their experiments more effectively, ensuring reliable and accurate results.

    01/27/2019

      They have a deep understanding of the CTSK protein and can provide valuable insights into its characteristics, properties, and optimal experimental conditions.

      12/14/2016

        the manufacturer offers outstanding technical support, serving as a valuable resource to resolve any issues that may arise during my research.

        Q&As (5)

        Ask a question
        Can CTSK be a target for the development of novel therapeutics for periodontal diseases? 10/10/2022

        Yes, CTSK inhibitors are being investigated for their potential in preventing bone loss associated with periodontal diseases.

        How does CTSK contribute to the progression of atherosclerosis, and can it be a therapeutic target for cardiovascular diseases? 01/22/2020

        CTSK has been linked to vascular calcification in atherosclerosis, and inhibiting its activity may have potential as a therapeutic strategy for cardiovascular diseases.

        How might CTSK inhibitors impact the treatment landscape for bone metastasis in cancer patients? 03/26/2018

        CTSK inhibitors could potentially be used to limit bone destruction in cancer patients with bone metastasis, improving their quality of life.

        Are there any other medical conditions where CTSK inhibitors could be beneficial? 07/29/2017

        CTSK inhibitors are being explored for potential therapeutic applications in conditions like rheumatoid arthritis and certain cancers due to their involvement in tissue remodeling.

        Are there diagnostic applications for CTSK in identifying bone-related disorders? 11/22/2016

        While CTSK is not currently used as a diagnostic marker, its levels and activity could potentially be explored for diagnostic purposes in the future.

        Ask a Question for All Ctsk Products

        Required fields are marked with *

        My Review for All Ctsk Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /
        • Service lnquiry:

        Stay Updated on the Latest Bioscience Trends